Christopher R Nicholas1, N Maritza Dowling2, Annie M Racine3, Lindsay R Clark1, Sara E Berman3, Rebecca L Koscik4, Sanjay Asthana1, Bruce Hermann4, Mark A Sager4, Sterling C Johnson1. 1. 1Geriatric Research Education and Clinical Center,Wm. S. Middleton Veterans Hospital,Madison,Wisconsin. 2. 4Department of Biostatistics & Research,School of Nursing,George Washington University,Washington,DC. 3. 3Wisconsin Alzheimer's Disease Research Center,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin. 4. 2Wisconsin Alzheimer's Institute,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
Abstract
OBJECTIVES: The purpose of this study was to investigate the longitudinal trajectory of self- and informant-subjective cognitive complaints (SCC), and to determine if SCC predict longitudinal changes in objective measures (OM) of cognitive function. METHODS: The study included healthy and cognitively normal late middle-aged adults enriched with a family history of AD who were evaluated at up to three visits over a 4-year period. At each visit (Visit 1-3), self- and informant-SCC and OM were evaluated. Linear mixed models were used to determine if the longitudinal rate of change of self- and informant-SCC were associated with demographic variables, depressive symptoms, family history (FH), and apolipoprotein epsilon 4 (APOE4) status. The same modeling approach was used to examine the effect of Visit 1 SCC on longitudinal cognitive change after controlling for the same variables. RESULTS: At Visit 1, more self-SCC were associated with fewer years of education and more depressive symptoms. SCC were also associated with poorer performance on cognitive measures, such that more self-SCC at Visit 1 were associated with poorer performance on memory and executive functioning measures at Visit 1, while more informant-SCC were associated with faster rate of longitudinal decline on a measure of episodic learning and memory. FH and APOE4 status were not associated with SCC. DISCUSSION: Self- and informant-SCC showed an association with OM, albeit over different time frames in our late middle-aged sample. Additional longitudinal follow-up will likely assist in further clarifying these relationships as our sample ages and more pronounced cognitive changes eventually emerge. (JINS, 2017, 23, 617-626).
OBJECTIVES: The purpose of this study was to investigate the longitudinal trajectory of self- and informant-subjective cognitive complaints (SCC), and to determine if SCC predict longitudinal changes in objective measures (OM) of cognitive function. METHODS: The study included healthy and cognitively normal late middle-aged adults enriched with a family history of AD who were evaluated at up to three visits over a 4-year period. At each visit (Visit 1-3), self- and informant-SCC and OM were evaluated. Linear mixed models were used to determine if the longitudinal rate of change of self- and informant-SCC were associated with demographic variables, depressive symptoms, family history (FH), and apolipoprotein epsilon 4 (APOE4) status. The same modeling approach was used to examine the effect of Visit 1 SCC on longitudinal cognitive change after controlling for the same variables. RESULTS: At Visit 1, more self-SCC were associated with fewer years of education and more depressive symptoms. SCC were also associated with poorer performance on cognitive measures, such that more self-SCC at Visit 1 were associated with poorer performance on memory and executive functioning measures at Visit 1, while more informant-SCC were associated with faster rate of longitudinal decline on a measure of episodic learning and memory. FH and APOE4 status were not associated with SCC. DISCUSSION: Self- and informant-SCC showed an association with OM, albeit over different time frames in our late middle-aged sample. Additional longitudinal follow-up will likely assist in further clarifying these relationships as our sample ages and more pronounced cognitive changes eventually emerge. (JINS, 2017, 23, 617-626).
Authors: Katherine A Gifford; Dandan Liu; Hugo Carmona; Zengqi Lu; Raymond Romano; Yorghos Tripodis; Brett Martin; Neil Kowall; Angela L Jefferson Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Katherine A Gifford; Dandan Liu; Zengqi Lu; Yorghos Tripodis; Nicole G Cantwell; Joseph Palmisano; Neil Kowall; Angela L Jefferson Journal: Alzheimers Dement Date: 2013-07-16 Impact factor: 21.566
Authors: Frank Jessen; Rebecca E Amariglio; Rachel F Buckley; Wiesje M van der Flier; Ying Han; José Luis Molinuevo; Laura Rabin; Dorene M Rentz; Octavio Rodriguez-Gomez; Andrew J Saykin; Sietske A M Sikkes; Colette M Smart; Steffen Wolfsgruber; Michael Wagner Journal: Lancet Neurol Date: 2020-01-17 Impact factor: 44.182
Authors: Julia K Stroehlein; Solveig Vieluf; Philipp Zimmer; Alexander Schenk; Max Oberste; Christian Goelz; Franziska van den Bongard; Claus Reinsberger Journal: BMC Neurol Date: 2021-05-17 Impact factor: 2.474
Authors: Leah Zuroff; Laura Em Wisse; Trevor Glenn; Sharon X Xie; Ilya M Nasrallah; Mohamad Habes; Jacob Dubroff; Robin de Flores; Long Xie; Paul Yushkevich; Jimit Doshi; Christos Davatsikos; Leslie M Shaw; Thomas F Tropea; Alice S Chen-Plotkin; David A Wolk; Sandhitsu Das; Dawn Mechanic-Hamilton Journal: J Alzheimers Dis Rep Date: 2022-07-22
Authors: Laura A Rabin; Crystal G Guayara-Quinn; Caroline O Nester; Liam Ellis; Nadia Paré Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2021-02-23